Preprint / Version 1

Molecular basis of HACD-TECR complex mediated very-long-chain fatty acid elongation reveal a potential target in colorectal cancer

This article is a preprint and has not been certified by peer review.

Authors

Categories
Keywords
VLCFAs; colorectal cancer; elongation; HACD; TECR

Abstract

Very long-chain fatty acids (VLCFAs) are crucial for lipid homeostasis and physiological functions. The elongation of VLCFAs, which is mediated by four consecutive enzymes in the endoplasmic reticulum (ER), has been implicated in tumor progression. However, the molecular mechanisms underlying VLCFA elongation enzymes and their specific contributions to tumorigenesis remain largely elusive. Here, we demonstrate that trans-2-enoyl-CoA reductase (TECR) is upregulated in colorectal cancer (CRC). Structural and biochemical analyses revealed a conserved catalytic mechanism for TECR-mediated trans-2-enoyl-CoA reduction. Moreover, we show that TECR forms a stable complex with 3-hydroxyacyl-CoA dehydratase (HACD), to cooperatively drive VLCFA elongation. A unique U-shaped loop in HACD is critical for recognizing TECR. Disruption of the HACD–TECR interaction interface significantly suppresses CRC cell growth. Collectively, these findings elucidate the molecular mechanism of HACD–TECR-mediated VLCFA elongation and suggest a potential therapeutic strategy for CRC treatment by modulating VLCFA metabolism.

 

 

References

1. Jakobsson, A., R. Westerberg, and A. Jacobsson, Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res, 2006. 45(3): p. 237-49.

2. Kyselová, L., M. Vitová, and T. Rezanka, Very long chain fatty acids. Prog Lipid Res, 2022. 87: p. 101180.

3. Yeboah, G. K., et al., Very long chain fatty acid-containing lipids: a decade of novel insights from the study of ELOVL4. J Lipid Res, 2021. 62: p. 100030.

4. Kihara, A., Very long-chain fatty acids: elongation, physiology and related disorders. J Biochem, 2012. 152(5): p. 387-95.

5. Sassa, T. and A. Kihara, Metabolism of very long-chain Fatty acids: genes and pathophysiology. Biomol Ther(Seoul), 2014. 22(2): p. 83-92.

6. Wang, X., et al., A comprehensive review of the family of very-long-chain fatty acid elongases: structure, function, and implications in physiology and pathology. Eur J Med Res, 2023. 28(1): p. 532.

7. Guillou, H., et al., The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice. Prog Lipid Res, 2010. 49(2): p. 186-99.

8. Moon, Y. A. and J. D. Horton, Identification of two mammalian reductases involved in the two-carbon fatty acyl elongation cascade. J Biol Chem, 2003. 278(9): p. 7335-43.

9. Ikeda, M., et al., Characterization of four mammalian 3-hydroxyacyl-CoA dehydratases involved in very long-chain fatty acid synthesis. FEBS Lett, 2008. 582(16): p. 2435-40.

10. Ohno, Y., et al., ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis. Proc Natl Acad Sci U S A, 2010. 107(43): p. 18439-44.

11. Kato, R., et al., Catalytic mechanism of trans-2-enoyl-CoA reductases in the fatty acid elongation cycle and its cooperative action with fatty acid elongases. J Biol Chem, 2024. 300(2): p. 105656.

12. Zhou, Y., et al., The 3-hydroxyacyl-CoA dehydratase 1/2 form complex with trans-2-enoyl-CoA reductase involved in substrates transfer in very long chain fatty acid elongation. Biochem Biophys Res Commun, 2024. 704: p. 149588.

13. Denic, V. and J. S. Weissman, A molecular caliper mechanism for determining very long-chain fatty acid length. Cell, 2007. 130(4): p. 663-77.

14. Konishi, H., et al., Characterization of HACD1 K64Q mutant found in arrhythmogenic right ventricular dysplasia patients. J Biochem, 2010. 148(5): p. 617-22.

15. Okuda, A., et al., Hetero-oligomeric interactions of an ELOVL4 mutant associated with stargardt-3 macular dystrophy. Mol Vis, 2010. 16: p. 2438-45.

16. Naganuma, T. and A. Kihara, Two modes of regulation of the fatty acid elongase ELOVL6 by the 3-ketoacyl-CoA reductase KAR in the fatty acid elongation cycle. PLoS One, 2014. 9(7): p. e101823.

17. Abe, K., et al., Mutation for nonsyndromic mental retardation in the trans-2-enoyl-CoA reductase TER gene involved in fatty acid elongation impairs the enzyme activity and stability, leading to change in sphingolipid profile. J Biol Chem, 2013. 288(51): p. 36741-9.

18. Hoy, A. J., S. R. Nagarajan, and L. M. Butler, Tumour fatty acid metabolism in the context of therapy resistance and obesity. Nat Rev Cancer, 2021. 21(12): p. 753-766.

19. Snaebjornsson, M. T., S. Janaki-Raman, and A. Schulze, Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer. Cell Metab, 2020. 31(1): p. 62-76.

20. Jin, H. R., et al., Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. J Hematol Oncol, 2023. 16(1): p. 103.

21. Tamura, K., et al., Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism. Cancer Res, 2009. 69(20): p. 8133-40.

22. Wan, M., et al., Lipid metabolic reprogramming: the unsung hero in breast cancer progression and tumor microenvironment. Mol Cancer, 2025. 24(1): p. 61.

23. Röhrig, F. and A. Schulze, The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer, 2016. 16(11): p. 732-749.

24. Hama, K., et al., Very long-chain fatty acids are accumulated in triacylglycerol and nonesterified forms in colorectal cancer tissues. Sci Rep, 2021. 11(1): p. 6163.

25. Marien, E., et al., Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma. Oncotarget, 2016. 7(11): p. 12582-97.

26. Yamashita, Y., et al., Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer. BMC Cancer, 2017. 17(1): p. 589.

27. Chu, Q., et al., Stearate-derived very long-chain fatty acids are indispensable to tumor growth. Embo j, 2023. 42(2): p. e111268.

28. Xie, Y. H., Y. X. Chen, and J. Y. Fang, Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther, 2020. 5(1): p. 22.

29. Liu, Y., et al., Genome-wide circular RNA (circRNA) and mRNA profiling identify a circMET-miR-410-3p regulatory motif for cell growth in colorectal cancer. Genomics, 2022. 114(1): p. 351-360.

30. Lee, H. O., et al., Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer. Nat Genet, 2020. 52(6): p. 594-603.

31. Han, Y., et al., Crystal structure of steroid reductase SRD5A reveals conserved steroid reduction mechanism. Nat Commun, 2021. 12(1): p. 449.

32. Xiao, Q., et al., Structure of human steroid 5alpha-reductase 2 with the anti-androgen drug finasteride. Nat Commun, 2020. 11(1): p. 5430.

33. Nie, L., et al., The structural basis of fatty acid elongation by the ELOVL elongases. Nat Struct Mol Biol, 2021. 28(6): p. 512-520.

34. Kihara, A., et al., Membrane topology and essential amino acid residues of Phs1, a 3-hydroxyacyl-CoA dehydratase involved in very long-chain fatty acid elongation. J Biol Chem, 2008. 283(17): p. 11199-209.

35. Aggarwal, S., et al., An overview on 5alpha-reductase inhibitors. Steroids, 2010. 75(2): p. 109-53.

36. Cilotti, A., G. Danza, and M. Serio, Clinical application of 5alpha-reductase inhibitors. Endocrinol Invest, 2001. 24(3): p. 199-203.

37. Roehrborn, C. G., et al., Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology, 2002. 60(3): p. 434-41.

38. Bray, F., et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018. 68(6): p. 394-424.

39. Huang, T. X., et al., ATP6V0A1-dependent cholesterol absorption in colorectal cancer cells triggers immunosuppressive signaling to inactivate memory CD8(+) T cells. Nat Commun, 2024. 15(1): p. 5680.

40. Mana, M. D., et al., High-fat diet-activated fatty acid oxidation mediates intestinal stemness and tumorigenicity. Cell Rep, 2021. 35(10): p. 109212.

41. Liu, X., et al., Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy. Sci Transl Med, 2021. 13(587).

42. Mastronarde, D. N., SerialEM: A Program for Automated Tilt Series Acquisition on Tecnai Microscopes Using Prediction of Specimen Position. Microscopy and Microanalysis, 2003. 9(S02): p. 1182-1183.

43. Zheng, S. Q., et al., MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat Methods, 2017. 14(4): p. 331-332.

44. Punjani, A., et al., cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods, 2017. 14(3): p. 290-296.

45. Emsley, P. and K. Cowtan, Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr, 2004. 60(Pt 12 Pt 1): p. 2126-32.

46. Adams, P. D., et al., PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr, 2010. 66(Pt 2): p. 213-21.

47. Pettersen, E. F., et al., UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem, 2004. 25(13): p. 1605-12.

48. Pettersen, E. F., et al., UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci, 2021. 30(1): p. 70-82.

Metrics

Views: 25
Downloads: 4

Downloads

Additional Files

Supplemental File(s)

Posted

2026-04-23

How to Cite

Lv, R., Yu, L., Liu, J., Zhou, Y., He, R., Wang, C., Gan, B., Ti, R., Jiao, H., Song, B., Chen, Y., Lin, F., Gao, M., Hu, H., Yin, S., Zhou, P., Zhu, L., Cai, M., Xie, T., … Ren, R. (2026). Molecular basis of HACD-TECR complex mediated very-long-chain fatty acid elongation reveal a potential target in colorectal cancer. LangTaoSha Preprint Server. https://doi.org/10.65215/LTSpreprints.2026.04.23.000200

Download Citation

Declaration of Competing Interests

The authors declare no competing interests to disclose.